The novel serine/threonine protein kinase LmjF.22.0810 from leishmania major may be involved in the resistance to drugs such as paromomycin

The novel serine/threonine protein kinase LmjF.22.0810 from leishmania major may be involved in the resistance to drugs such as paromomycin

The identification and clarification of the mechanisms of action of drugs used against leishmaniasis may improve their administration regimens and prevent the development of resistant strains. Herein, for the first time, we describe the structure of the putatively essential Ser/Thr kinase LmjF.22...

Full description

Bibliographic Details
Main Authors: Vacas, A. (Andrés), Fernández-Rubio, C. (Celia), Algarabel, M. (Miriam), Peña-Guerrero, J. (José), Larrea, E. (Esther), Formiga, F.R. (Fabio R.), García-Sosa, A.T. (Alfonso T.), Nguewa, P.A. (Paul Alain)
Format: info:eu-repo/semantics/article
Language:eng
Published: MDPI AG 2022
Subjects:
Leishmania
NTD
Docking
Molecular dynamics
Drug resistance
Paromomycin
Kinase
Treatment
LmjF.22.0810
LmJean3
Online Access:https://hdl.handle.net/10171/62954

Internet

https://hdl.handle.net/10171/62954

Similar Items